Insider Stock Trading History of Neylan John F.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Neylan John F. since year 2005. The trader's CIK number is 1640447. At the time of this reporting, Neylan John F. is the Chief Medical Officer of Keryx Biopharmaceuticals Inc . (stock ticker symbol KERX). See this page for all insider trading activities at Keryx Biopharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Neylan John F. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-07-31 KERX Keryx Biopharmaceuticals Inc Sale 1,445 7.14 10,317
2017-07-24 KERX Keryx Biopharmaceuticals Inc Sale 1,214 7.27 8,825
2017-05-01 KERX Keryx Biopharmaceuticals Inc Sale 1,441 5.97 8,602
2017-04-24 KERX Keryx Biopharmaceuticals Inc Sale 1,209 5.73 6,927
2017-01-30 KERX Keryx Biopharmaceuticals Inc Sale 6,984 4.65 32,475
2017-01-23 KERX Keryx Biopharmaceuticals Inc Sale 1,428 5.39 7,696
2016-10-24 KERX Keryx Biopharmaceuticals Inc Sale 1,211 4.72 5,715
2016-07-25 KERX Keryx Biopharmaceuticals Inc Sale 1,217 7.43 9,042
2016-04-25 KERX Keryx Biopharmaceuticals Inc Sale 4,766 5.21 24,830
2015-08-12 KERX Keryx Biopharmaceuticals Inc Buy 10,000 6.20 62,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Neylan John F. (Chief Medical Officer of Keryx Biopharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.